CVE-2026-21997 Details
Description
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
A vulnerability exists in Oracle Life Sciences Empirica Signal versions 9.2.1 through 9.2.3, within the Common Core component. This easily exploitable vulnerability allows a low-privileged attacker with network access via HTTP to compromise the application. While the issue is contained within Empirica Signal, it may also significantly affect other products. Successful exploitation could lead to unauthorized creation, deletion, or modification of critical data, as well as unauthorized read access to a subset of data accessible within Empirica Signal.
Metrics
CVSS 4.0 Severity and Vector Strings:
No CVSS 4.0 data is available for this CVE.
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed Apr 22, 2026References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://www.oracle.com/security-alerts/cpuapr2026.html | [email protected] | Vendor Advisory |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-284 | Improper Access Control | CISA-ADP |
Affected Products
| Product | Versions |
|---|---|
| oracle life sciences empirica signal | >= 9.2.1, <= 9.2.3 |
CPE
Remediation
| |
Change History
6 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Oct 26, 2026 | CVE Translated | [email protected] |
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| May 1, 2026 | Initial Analysis | [email protected] |
| Apr 22, 2026 | CVE Modified | CISA-ADP |
| Apr 21, 2026 | New CVE Received | [email protected] |